Literature DB >> 8033570

Some factors influencing outcome after keratoprosthesis surgery.

C H Dohlman1, M G Doane.   

Abstract

Eleven patients with severe corneal disease have been operated with a collar-button-shaped keratoprosthesis and have been followed for 9-36 months. Two of the devices have been removed, but the remainder are securely in place. Six of the patients have benefitted substantially in terms of improved vision. The complications have been reviewed, and some factors for success have been identified. Thus, to keep the keratoprosthesis temporarily buried beneath tissue (conjunctiva or skin), application of collagenase-suppressing medication and reduction of evaporative damage to the wound around the device seem particularly important.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033570     DOI: 10.1097/00003226-199405000-00004

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  8 in total

1.  Novel materials to enhance keratoprosthesis integration.

Authors:  S R Sandeman; R G Faragher; M C Allen; C Liu; A W Lloyd
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Preparation and in vivo investigation of artificial cornea made of nano-hydroxyapatite/poly (vinyl alcohol) hydrogel composite.

Authors:  Xu Fenglan; Li Yubao; Yao Xiaoming; Liao Hongbing; Zhang Li
Journal:  J Mater Sci Mater Med       Date:  2007-04       Impact factor: 3.896

3.  The soft keratoprosthesis.

Authors:  D R Caldwell
Journal:  Trans Am Ophthalmol Soc       Date:  1997

4.  Hydroxyapatite promotes superior keratocyte adhesion and proliferation in comparison with current keratoprosthesis skirt materials.

Authors:  J S Mehta; C E Futter; S R Sandeman; R G A F Faragher; K A Hing; K E Tanner; B D S Allan
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

5.  Legeais BioKpro III keratoprosthesis implantation: long term results in seven patients.

Authors:  E J Hollick; S L Watson; J K G Dart; P J Luthert; B D S Allan
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

6.  Five year follow up of biocolonisable microporous fluorocarbon haptic (BIOKOP) keratoprosthesis implantation in patients with high risk of corneal graft failure.

Authors:  J L Alió; M E Mulet; H Haroun; J Merayo; J M Ruiz Moreno
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

7.  High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis.

Authors:  Brett L Shapiro; Dennis E Cortés; Eric K Chin; Jennifer Y Li; John S Werner; Ellen Redenbo; Mark J Mannis
Journal:  Cornea       Date:  2013-07       Impact factor: 2.651

8.  Three-dimensional anterior segment imaging in patients with type 1 Boston Keratoprosthesis with switchable full depth range swept source optical coherence tomography.

Authors:  Raju Poddar; Poddar Raju; Dennis E Cortés; John S Werner; Mark J Mannis; Robert J Zawadzki
Journal:  J Biomed Opt       Date:  2013-08       Impact factor: 3.170

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.